Deciphering the differential impact of CDK4 mutations on abemaciclib binding in oral squamous cell carcinoma: a precision medicine approach
Crossref DOI link: https://doi.org/10.1007/s11845-025-03994-5
Published Online: 2025-07-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Yu
Zhang, Mi
Ni, Yi
Text and Data Mining valid from 2025-07-21
Version of Record valid from 2025-07-21
Article History
Received: 11 April 2025
Accepted: 23 June 2025
First Online: 21 July 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.